Venlafaxine Hydrochloride
Product Images NDC 53002-1361

7 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 53002-1361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Venlafaxine Hydrochloride (Image 1)

Structural Formula For Venlafaxine Hydrochloride (Image 1)
A pharmacokinetic interaction chart for venlafaxine showing the fold change in Cmax and AUC when coadministered with various interacting drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The chart displays recommendations such as dose adjustments or cautions based on these interactions, with fold changes plotted relative to a reference value of 1.*
FDA Label Image

1 (Image 2)

1 (Image 2)
A chart illustrating the pharmacokinetic fold change (Cmax and AUC) and 90% confidence intervals for Venlafaxine Hydrochloride interacting with various drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The horizontal axis represents change relative to the reference value, with recommendations on dose adjustment and clinical significance indicated for each interaction.*
FDA Label Image

2 (Image 3)

2 (Image 3)
A scatter plot chart illustrating fold changes and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of venlafaxine and its metabolite ODV across various special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. Recommendations for dose adjustments are noted per group, ranging from dose reduction to no adjustment, with change relative to reference values displayed on the horizontal axis.*
FDA Label Image

3 (Image 4)

3 (Image 4)
Chemical structure of venlafaxine hydrochloride showing its molecular arrangement including the methoxyphenyl group, cyclohexanol ring, dimethylamino group, and associated hydrochloride moiety.*
FDA Label Image

Label Image (Lbl530021361)

Label Image (Lbl530021361)
Venlafaxine Hydrochloride 150mg ER-Capsules carton label from RPK Pharmaceuticals, Inc. The label instructs to take 1 capsule daily or as directed and lists a package size of 30 capsules. It includes patient information, storage, and disposal instructions along with lot, expiration, and NDC numbers.*
FDA Label Image

Label Image (Lbl530021365)

Label Image (Lbl530021365)
Venlafaxine Hydrochloride 75mg ER-Capsules packaging label from RPK Pharmaceuticals, Inc. The label is for a bottle containing 30 extended-release capsules. Instructions indicate taking one capsule daily or as directed. The label includes barcode, lot number, and expiration date details.*
FDA Label Image

Label Image (Lbl530021366)

Label Image (Lbl530021366)
Venlafaxine Hydrochloride 37.5 mg extended-release capsules packaging label by RPK Pharmaceuticals, Inc. The label indicates the product contains 30 capsules. Directions state to take one capsule daily or as directed. Additional labeling includes barcode, lot number, expiration date, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.